A team of eminent scientists has concluded that surges in epilepsy and appendicitis in children were caused by Covid mRNA shots.
According to a new study, children who received the AstraZeneca or Pfizer-BioNTech Covid injections faced an elevated risk of epilepsy and appendicitis.
The researchers also found that Pfizer recipients were more likely to suffer from demyelinating disease or heart inflammation.
The study was led by Dr. Julia Hippisley-Cox, a world-renowned professor of clinical epidemiology at the University of Oxford’s Nuffield Department of Primary Health Care Sciences.
The paper for the peer-reviewed study was published in the prestigious Nature Medical Journal.
Dr. Julia Hippisley-Cox and her team of researchers obtained data from a national database on Covid vaccination, mortality, hospital admissions, and COVID-19 infections.
They wanted to look at the link between Covid shots from AstraZeneca, Pfizer, and Moderna with 12 outcomes, including the heart inflammation condition called myocarditis.
Myocarditis is an inflammation of the heart muscle that restricts the body’s ability to pump blood.
It can lead to cardiac arrest, strokes, blood clots, and sudden death.
The population of nearly 5.2 million included 1.8 million children aged 5 to 11 and 3.3 million children aged 12 to 17.
The official UK government data sets examined were through August 7, 2022.
In the primary analysis, researchers found 12- to 17-year-olds who received Pfizer’s vaccine were at increased risk of myocarditis.
They saw an additional three cases per million versus the expected rate after the first dose and an additional five cases per million after a second dose.
The data also revealed hospitalization with epilepsy increased, with an additional 12 cases per million after a second dose.
Females in the age group also faced an increased risk of demyelinating disease after receiving a second dose of the vaccine.
Researchers also identified a “substantially increased risk of hospitalization with epilepsy” among females after receipt of a first dose of AstraZeneca’s shot.
They found 813 more hospitalizations with epilepsy than expected per million doses.
An elevated risk of appendicitis was identified after a second dose of the vaccine, with 512 excess events per million doses.
While no excess events were found among Moderna recipients, the study lacked the power to detect statistically significant issues.
This was due to few children in the UK receiving Moderna’s vaccine.
Further, no elevated risks of the 12 issues were found among 5- to 11-year-olds.
A secondary analysis, involving matching some of the vaccine recipients to unvaccinated children, confirmed an increased risk among 12- to 17-year-olds of hospitalization with epilepsy following Pfizer vaccination.
They found an elevated risk of severe allergic shock and appendicitis in the age group following the Pfizer vaccination.
No increased risks of any outcome were identified among minor Moderna or AstraZeneca recipients.
However, among a group of 18- to 24-year-olds studied, elevated risks of a number of conditions were found.
Those conditions include myocarditis, immune or idiopathic thrombocytopenia, epilepsy, and acute pancreatitis.
The study was funded by the U.S. National Institute for Health (NIH) and the Care Research School for Primary Care Research.
Multiple authors declared conflicts of interest, including funding from Moderna and AstraZeneca.
Limitations included reliance on hospital admission codes and death certificates.
The authors said that their findings “support a favorable safety profile of COVID-19 vaccination using mRNA vaccines in children and young people aged 5-17 years.”
The Pfizer and Moderna shots utilize messenger ribonucleic acid (mRNA) technology.
The authors cited in part how they found unvaccinated children faced increased risks of some of the outcomes, including multisystem inflammatory syndrome in children.
Udi Qimron, a professor at Tel Aviv University’s Department of Clinical Microbiology and Immunology, argues that the authors wrongly downplayed the risks associated with the vaccines.
“It’s not surprising to learn that some of the study’s authors have financial ties to Moderna and AstraZeneca and/or have served on various UK and Scottish Government COVID-19 advisory groups,” Qimron said in a statement responding to the study.
“One author was even a member of AstraZeneca’s Thrombotic Thrombocytopenic Taskforce and the Joint Committee on Vaccination and Immunisation.
“The conflict of interest in this case is significant.”
“It is concerning that respected scientific platforms are being used to cover up mistakes and wrongdoing, particularly the coercion and immense societal pressure to vaccinate young children,” he added.
“This should never have been done.
“It is disheartening to see scientific journals collaborating with such practices, which undermines public trust in scientific research, especially when it involves the health and safety of children.”
No comments:
Post a Comment